These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 25739941)
1. Low-dose arsenic trioxide combined with aclacinomycin A synergistically enhances the cytotoxic effect on human acute myelogenous leukemia cell lines by induction of apoptosis. Ye Y; Xu X; Zhang M; Qiu D; Bai X; Wang J; Weng G; Zhou R; Guo Z; He H; Yi W; He X; Guo K Leuk Lymphoma; 2015; 56(11):3159-67. PubMed ID: 25739941 [TBL] [Abstract][Full Text] [Related]
2. [Synergistic lethal effect of combined treatment of arsenic trioxide and aclacinomycin on human acute myeloid leukemia cell line KG-1a]. Ye YB; Xu XJ; Chen YH; Zhang MW; Qiu DF; Guo ZW; He HQ Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):256-262. PubMed ID: 28550664 [No Abstract] [Full Text] [Related]
3. Low-dose 1,25-dihydroxyvitamin D(3) combined with arsenic trioxide synergistically inhibits proliferation of acute myeloid leukemia cells by promoting apoptosis. Bae JY; Kim JW; Kim I Oncol Rep; 2013 Jul; 30(1):485-91. PubMed ID: 23660868 [TBL] [Abstract][Full Text] [Related]
4. Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance. Lehmann S; Bengtzen S; Paul A; Christensson B; Paul C Eur J Haematol; 2001 Jun; 66(6):357-64. PubMed ID: 11488934 [TBL] [Abstract][Full Text] [Related]
5. The mechanism of synergistic effects of arsenic trioxide and rapamycin in acute myeloid leukemia cell lines lacking typical t(15;17) translocation. Dembitz V; Lalic H; Ostojic A; Vrhovac R; Banfic H; Visnjic D Int J Hematol; 2015 Jul; 102(1):12-24. PubMed ID: 25758096 [TBL] [Abstract][Full Text] [Related]
6. Thioredoxin-1 inhibitor PX-12 induces human acute myeloid leukemia cell apoptosis and enhances the sensitivity of cells to arsenic trioxide. Tan Y; Bi L; Zhang P; Wang F; Lin F; Ni W; Wu J; Jiang L Int J Clin Exp Pathol; 2014; 7(8):4765-73. PubMed ID: 25197347 [TBL] [Abstract][Full Text] [Related]
7. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Zhang W; Ohnishi K; Shigeno K; Fujisawa S; Naito K; Nakamura S; Takeshita K; Takeshita A; Ohno R Leukemia; 1998 Sep; 12(9):1383-91. PubMed ID: 9737686 [TBL] [Abstract][Full Text] [Related]
8. Dual effects of arsenic trioxide (As2O3) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation. Rojewski MT; Baldus C; Knauf W; Thiel E; Schrezenmeier H Br J Haematol; 2002 Mar; 116(3):555-63. PubMed ID: 11849211 [TBL] [Abstract][Full Text] [Related]
9. Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines. Lu M; Levin J; Sulpice E; Sequeira-Le Grand A; Alemany M; Caen JP; Han ZC Exp Hematol; 1999 May; 27(5):845-52. PubMed ID: 10340400 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of wt1 expression in leukemia cell lines as part of apoptotic effect in arsenic treatment using two compounds. Glienke W; Chow KU; Bauer N; Bergmann L Leuk Lymphoma; 2006 Aug; 47(8):1629-38. PubMed ID: 16966277 [TBL] [Abstract][Full Text] [Related]
11. Omega-3 and omega-6 polyunsaturated fatty acids enhance arsenic trioxide efficacy in arsenic trioxide-resistant leukemic and solid tumor cells. Wirtitsch M; Roth E; Bachleitner-Hofmann T; Wessner B; Sturlan S Oncol Res; 2009; 18(2-3):83-94. PubMed ID: 20066898 [TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction. Li H; Zhu X; Zhang Y; Xiang J; Chen H J Exp Clin Cancer Res; 2009 Aug; 28(1):110. PubMed ID: 19664237 [TBL] [Abstract][Full Text] [Related]
13. Dose- and time-dependent response of human leukemia (HL-60) cells to arsenic trioxide treatment. Yedjou CG; Moore P; Tchounwou PB Int J Environ Res Public Health; 2006 Jun; 3(2):136-40. PubMed ID: 16823087 [TBL] [Abstract][Full Text] [Related]
14. The role of mitochondrial targeting in arsenic trioxide-induced apoptosis in myeloid cell lines. Körper S; Nolte F; Thiel E; Schrezenmeier H; Rojewski MT Br J Haematol; 2004 Jan; 124(2):186-9. PubMed ID: 14687028 [TBL] [Abstract][Full Text] [Related]
15. [Potentiation of arsenic trioxide-induced apoptosis by retinoic acid in retinoic acid sensitive and resistant HL-60 myeloid leukemia cells]. Huang X Chin Med J (Engl); 2000 Jun; 113(6):498-501. PubMed ID: 11775865 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors. Wu EJ; Goussetis DJ; Beauchamp E; Kosciuczuk EM; Altman JK; Eklund EA; Platanias LC Cancer Biol Ther; 2014 Apr; 15(4):473-8. PubMed ID: 24496081 [TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide inhibits cell growth in SH-SY5Y and SK-N-AS neuroblastoma cell lines by a different mechanism. Woo SY; Lee MY; Jung YJ; Yoo ES; Seoh JY; Shin HY; Ahn HS; Ryu KH Pediatr Hematol Oncol; 2006; 23(3):231-43. PubMed ID: 16517539 [TBL] [Abstract][Full Text] [Related]
18. [Effects of Arsenic Trioxide on Cdc20 and Mad2 in Acute Myeloid Leukemia HL-60 Cell Line]. Ding SM; Xu RR; Kan JY; Wang Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):710-715. PubMed ID: 29950208 [TBL] [Abstract][Full Text] [Related]
19. [In vitro effect of bortezomib alone or in combination with harringtonine or arsenic trioxide on proliferation and apoptosis of multidrug resistant leukemia cells]. Cai YX; Meng FY; Sun QX; Fu YB; Li L Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):737-40. PubMed ID: 19176009 [TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system. Zhu J; Okumura H; Ohtake S; Nakamura S; Nakao S Oncol Rep; 2003; 10(3):705-9. PubMed ID: 12684647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]